表紙
市場調查報告書

全球幹細胞市場預測(2021-2028)

Global Stem Cell Market Forecast 2021-2028

出版商 Inkwood Research 商品編碼 969281
出版日期 內容資訊 英文 310 Pages
商品交期: 2-3個工作天內
價格
全球幹細胞市場預測(2021-2028) Global Stem Cell Market Forecast 2021-2028
出版日期: 2020年11月09日內容資訊: 英文 310 Pages
簡介

在預測期內2021-2028年,全球幹細胞市場預計將以7.82%的複合年增長率增長。推動市場增長的關鍵因素包括:再生醫學對幹細胞的需求增加,對臍帶幹細胞的認識提高,對幹細胞治療和研究的研發投資激增以及技術進步。

幹細胞具有驚人的潛力,因為副分泌促進傷口修復和皮膚組織再生。目前,作為間質幹細胞,許多細胞類型,胚胎幹細胞,上皮幹細胞,駐留組織幹細胞,造血幹細胞和脂肪來源的幹細胞正在被廣泛研究,並且可能有助於市場的顯著增長。

該報告調查了全球幹細胞市場,包括市場規模和估計,增長和限制因素,COVID-19的影響以及按治療用途/產品/技術/用途/治療類型/地區進行的市場分析,競爭狀況,主要公司的概況等

目錄

第1章調查範圍和調查方法

  • 調查目的
  • 調查範圍
  • 調查方法
  • 先決條件和限制

第2章執行摘要

  • 市場規模/估計
  • 市場概況

第3章市場動態

  • 主要增長因素
    • 再生醫學對幹細胞的需求迅速增加
    • 擴大幹細胞療法和研發投資
    • 提高對臍帶血幹細胞的認識
    • 減少植入物中組織排斥的風險
    • 技術進步
  • 主要製約因素
    • 嚴格的政府法規
    • 與幹細胞療法相關的高成本
    • 與幹細胞有關的倫理問題和社會複雜性
    • 發達國家的響應能力下降

第4章主要分析

  • 波特的五力分析
  • COVID-19對幹細胞市場的影響
  • 價值鏈分析
  • 主要購買標準
  • 幹細胞的歷史
  • 監管框架
  • 機會矩陣
  • 供應商狀況
  • 主要投資見解

第五章按治療應用劃分的市場

  • 骨科治療
  • 傷害和傷口
  • 腫瘤疾病
  • 心血管疾病
  • 神經系統疾病
  • 糖尿病
  • 其他治療用途

第6章按產品劃分的市場

  • 成年幹細胞
    • 造血幹細胞
    • 神經幹
    • 臍帶幹細胞
    • 膜幹細胞
    • 牙科幹細胞
  • 人類胚胎幹細胞
  • 多才多藝
  • 小鼠/大鼠神經元

第7章按技術劃分的市場

  • 集合
    • 幹細胞骨髓
    • 幹細胞轉移
    • 幹細胞臍帶
  • 冷凍保存
  • 擴張與亞文化
  • 製造業
    • 幹細胞培養
    • 治療性克隆
    • 試管嬰兒

第8章按用途劃分的市場

  • 再生醫學
  • 藥物發現與開發

第9章按治療類型劃分的市場

  • 同種異體幹細胞療法
  • 自動幹細胞療法
  • 同義詞幹細胞療法

第10章區域分析

  • 北美
    • 市場規模/估計
    • 主要增長動力
    • 主要問題
    • 主要公司
    • 國家分析
  • 歐洲
  • 亞太地區
  • 其他地區

第11章競爭情況

  • 主要戰略發展
    • 併購
    • 產品發佈和開發
    • 聯盟,合同與合作
    • 業務擴展/批准/公告
  • 公司簡介
    • ALLCELLS LLC
    • BECTON, DICKINSON AND COMPANY (BD)
    • CORNING INC
    • CYTORI THERAPEUTICS
    • GE HEALTHCARE
    • INTERNATIONAL STEM CELL CORP
    • MERCK KGAA (SIGMA ALDRICH)
    • MILTENYI BIOTEC
    • PLURISTEM THERAPEUTICS INC
    • QIAGEN NV
    • SMITH & NEPHEW PLC
    • STEMCELL TECHNOLOGIES
    • STRYKER CORPORATION
    • TAKARA HOLDINGS INC
    • THERMO FISHER SCIENTIFIC INC
目錄
Product Code: 4685

KEY FINDINGS

The global stem cell market is evaluated to grow with a CAGR of 7.82%, during the forecast period of 2021 to 2028. Primary factors driving the market growth include the rising demand for stem cells in regenerative medicine, growing awareness about umbilical cord stem cells, surging research and development investments in stem cell therapies and research, and technological advancements.

MARKET INSIGHTS

Stem cells possess remarkable potential, in terms of promoting wound repaid in a paracrine manner and cutaneous tissue regeneration. As mesenchymal stem cells, numerous cell types, embryonic stem cells, epithelial stem cells, resident tissue stem cells, hematopoietic stem cells, and adipose-derived stem cells are presently under extensive investigation. As a result, this is likely to contribute to the significant growth of the stem cell market.

Umbilical cord stem cells as a non-invasive and efficacious alternative source of hematopoietic stem cells are gaining added awareness and prevalence. They are primarily utilized for treating a varied range of blood-, metabolic-, bone-, and immune system-related disorders and diseases. Moreover, the knowledge regarding the importance of the umbilical cord, as well as its applications, especially across developed markets, is steadily increasing.

REGIONAL INSIGHTS

The global stem cell market growth analysis includes the Asia Pacific, Europe, North America, and the rest of the world. The Asia Pacific observes an increased incidence of chronic diseases, such as cancer, in addition to growing medical tourism in developing nations like India and China, as well as improved economic stability. As a result, the region is anticipated to be the fastest-growing market for stem cells.

COMPETITIVE INSIGHTS

Since stem cells play a crucial role in toxicology studies and drug discovery, the intensity towards optimizing the technical strength for stem cells is continually growing. This factor is also crucial in bolstering the growth of the companies operating in the market. Hence, the degree of competitive rivalry is anticipated to increase further, and remain high, over the forecast period. The market's key players include, Corning Inc, Becton, Dickinson and Company (BD), GE Healthcare, Smith & Nephew PLC, Qiagen NV, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
    • 3.1.2. GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
    • 3.1.3. RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
    • 3.1.4. REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 3.2.2. HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
    • 3.2.3. ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
    • 3.2.4. LESS RESPONSIVENESS IN DEVELOPED ECONOMIES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON STEM CELL MARKET
  • 4.3. VALUE CHAIN ANALYSIS
  • 4.4. KEY BUYING CRITERIA
  • 4.5. HISTORY OF STEM CELL
  • 4.6. REGULATORY FRAMEWORK
  • 4.7. OPPORTUNITY MATRIX
  • 4.8. VENDOR LANDSCAPE
  • 4.9. KEY INVESTMENT INSIGHTS

5. MARKET BY THERAPEUTIC APPLICATION

  • 5.1. ORTHOPEDIC TREATMENTS
  • 5.2. INJURIES AND WOUNDS
  • 5.3. ONCOLOGY DISORDERS
  • 5.4. CARDIOVASCULAR DISORDERS
  • 5.5. NEUROLOGICAL DISORDERS
  • 5.6. DIABETES
  • 5.7. OTHER THERAPEUTIC APPLICATIONS

6. MARKET BY PRODUCT

  • 6.1. ADULT STEM CELL
    • 6.1.1. HEMATOPOIETIC STEM CELL
    • 6.1.2. NEURAL STEM
    • 6.1.3. UMBILICAL CORD STEM CELL
    • 6.1.4. MESENCHYMAL STEM CELL
    • 6.1.5. DENTAL STEM CELL
  • 6.2. HUMAN EMBRYONIC STEM CELL
  • 6.3. PLURIPOTENT
  • 6.4. MOUSE/RAT NEURAL

7. MARKET BY TECHNOLOGY

  • 7.1. ACQUISITION
    • 7.1.1. STEM CELL BONE MARROW MARKET
    • 7.1.2. STEM CELL APHERESIS
    • 7.1.3. STEM CELL UMBILICAL CORD
  • 7.2. CRYOPRESERVATION
  • 7.3. EXPANSION AND SUB-CULTURE
  • 7.4. PRODUCTION
    • 7.4.1. STEM CELL CULTURE
    • 7.4.2. THERAPEUTIC CLONING
    • 7.4.3. IVF

8. MARKET BY APPLICATION

  • 8.1. REGENERATIVE MEDICINE
  • 8.2. DRUG DISCOVERY AND DEVELOPMENT

9. MARKET BY TREATMENT TYPE

  • 9.1. ALLOGENEIC STEM CELL THERAPY
  • 9.2. AUTOLOGIC STEM CELL THERAPY
  • 9.3. SYNGENEIC STEM CELL THERAPY

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. MARKET SIZE & ESTIMATES
    • 10.2.2. KEY GROWTH ENABLERS
    • 10.2.3. KEY CHALLENGES
    • 10.2.4. KEY PLAYERS
    • 10.2.5. COUNTRY ANALYSIS
      • 10.2.5.1. GERMANY
      • 10.2.5.2. FRANCE
      • 10.2.5.3. UNITED KINGDOM
      • 10.2.5.4. ITALY
      • 10.2.5.5. RUSSIA
      • 10.2.5.6. BELGIUM
      • 10.2.5.7. POLAND
      • 10.2.5.8. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. MARKET SIZE & ESTIMATES
    • 10.3.2. KEY GROWTH ENABLERS
    • 10.3.3. KEY CHALLENGES
    • 10.3.4. KEY PLAYERS
    • 10.3.5. COUNTRY ANALYSIS
      • 10.3.5.1. CHINA
      • 10.3.5.2. JAPAN
      • 10.3.5.3. INDIA
      • 10.3.5.4. AUSTRALIA & NEW ZEALAND
      • 10.3.5.5. SOUTH KOREA
      • 10.3.5.6. THAILAND
      • 10.3.5.7. INDONESIA
      • 10.3.5.8. VIETNAM
      • 10.3.5.9. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. MARKET SIZE & ESTIMATES
    • 10.4.2. KEY GROWTH ENABLERS
    • 10.4.3. KEY CHALLENGES
    • 10.4.4. KEY PLAYERS
    • 10.4.5. REGIONAL ANALYSIS
      • 10.4.5.1. LATIN AMERICA
      • 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGER & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 11.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 11.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 11.2. COMPANY PROFILE
    • 11.2.1. ALLCELLS LLC
    • 11.2.2. BECTON, DICKINSON AND COMPANY (BD)
    • 11.2.3. CORNING INC
    • 11.2.4. CYTORI THERAPEUTICS
    • 11.2.5. GE HEALTHCARE
    • 11.2.6. INTERNATIONAL STEM CELL CORP
    • 11.2.7. MERCK KGAA (SIGMA ALDRICH)
    • 11.2.8. MILTENYI BIOTEC
    • 11.2.9. PLURISTEM THERAPEUTICS INC
    • 11.2.10. QIAGEN NV
    • 11.2.11. SMITH & NEPHEW PLC
    • 11.2.12. STEMCELL TECHNOLOGIES
    • 11.2.13. STRYKER CORPORATION
    • 11.2.14. TAKARA HOLDINGS INC
    • 11.2.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - STEM CELL
  • TABLE 2: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ADULT STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL ADULT STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL NEURAL STEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL NEURAL STEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL DENTAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL DENTAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL PLURIPOTENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL PLURIPOTENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL ACQUISITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL ACQUISITION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 49: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 51: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL CRYOPRESERVATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 53: GLOBAL CRYOPRESERVATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 55: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 57: GLOBAL PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 59: GLOBAL PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL STEM CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 61: GLOBAL STEM CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 62: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 63: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 64: GLOBAL IVF MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 65: GLOBAL IVF MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 66: GLOBAL STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 67: GLOBAL STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 68: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 69: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 70: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 71: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 72: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 73: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 74: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 75: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 76: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 77: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 78: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 79: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 80: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 81: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 82: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 83: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 84: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET
  • TABLE 85: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 86: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 87: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET
  • TABLE 88: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 89: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 90: LEADING PLAYERS OPERATING IN ASIA PACIFIC STEM CELL MARKET
  • TABLE 91: REST OF WORLD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 92: REST OF WORLD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 93: LEADING PLAYERS OPERATING IN REST OF WORLD STEM CELL MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020
  • FIGURE 6: GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL STEM CELL MARKET, BY PRODUCT, IN 2020
  • FIGURE 14: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 24: GLOBAL STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL STEM CELL MARKET, BY APPLICATION, IN 2020
  • FIGURE 35: GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, IN 2020
  • FIGURE 38: GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 40: GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 41: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 42: UNITED STATES STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: CANADA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 45: GERMANY STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: FRANCE STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: UNITED KINGDOM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: ITALY STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: RUSSIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: BELGIUM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: POLAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: REST OF EUROPE STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: ASIA PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 54: CHINA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 55: JAPAN STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 56: INDIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 57: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 58: SOUTH KOREA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 59: THAILAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 60: INDONESIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 61: VIETNAM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 62: REST OF ASIA PACIFIC STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 63: REST OF WORLD STEM CELL MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 64: LATIN AMERICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 65: MIDDLE EAST & AFRICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)